Ameriprise Financial Inc Annexon, Inc. Transaction History
Ameriprise Financial Inc
- $375 Billion
- Q4 2024
A detailed history of Ameriprise Financial Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 926,642 shares of ANNX stock, worth $2.62 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
926,642
Previous 158,773
483.63%
Holding current value
$2.62 Million
Previous $939,000
406.18%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
98.2MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$21 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$19.8 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18.6 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$17.8 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$15.9 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $135M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...